https://scholars.lib.ntu.edu.tw/handle/123456789/564802
標題: | Ardisianone, a natural benzoquinone, efficiently induces apoptosis in human hormone-refractory prostate cancers through mitochondrial damage stress and survivin downregulation | 作者: | Yu C.-C. Wu P.-J. Hsu J.-L. Ho Y.-F. LIH-CHING HSU Chang Y.-J. Chang H.-S. Chen I.-S. JIH-HWA GUH |
公開日期: | 2013 | 卷: | 73 | 期: | 2 | 起(迄)頁: | 133-145 | 來源出版物: | Prostate | 摘要: | BACKGROUND Increasing evidence suggests that mitochondria play a central role in regulating cell apoptosis. Survivin, an inhibitor of apoptosis protein (IAP) family member, mediates resistance to cancer chemotherapy particularly in prostate cancers. Therefore, development of anticancer agents targeting mitochondria and survivin is a potential strategy. METHOD Cell proliferation was examined by sulforhodamine B, CFSE staining, and clonogenic assays. Mitochondrial membrane potential (δψm) and reactive oxygen species (ROS) were detected by flow cytometric analysis. Protein expression was detected by Western blot. RNA levels were examined by reverse transcription polymerase chain reaction assay. Overexpression of constitutively active Akt was also used in this study. RESULTS Ardisianone, a natural benzoquinone derivative, displayed anti-proliferative and apoptotic activities against human hormone-refractory prostate cancer cells (HRPC), PC-3, and DU-145. Ardisianone dramatically induced mitochondrial damage, identified by downregulation of Bcl-2 family proteins, ROS production, and loss of δψm. Ardisianone also inhibited Akt and mTOR/p70S6K pathways and induced a fast downregulation of survivin, leading to activation of mitochondria-involved caspase cascades. Overexpression of constitutively active Akt partly rescued ardisianone-mediated apoptotic signaling cascades. Furthermore, a long-term treatment of ardisianone caused an increase of endoplasmic reticulum (ER) stress, upregulation of cIAP1 and cIAP2, and apoptosis-inducing factor (AIF)-mediated caspase-independent apoptosis. CONCLUSIONS The data suggest that the ardisianone induces apoptosis in human prostate cancers through mitochondrial damage stress, leading to the inhibition of mTOR/p70S6K pathway, downregulation of Bcl-2 family members, degradation of survivin, and activation of caspase cascades. The data provide evidence supporting that ardisianone is a potential anticancer agent against HRPCs. Prostate 73: 133-145, 2013. ? 2012 Wiley Periodicals, Inc. Copyright ? 2012 Wiley Periodicals, Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871610611&doi=10.1002%2fpros.22548&partnerID=40&md5=7f9f97e36e6da10860e6c620110d767f https://scholars.lib.ntu.edu.tw/handle/123456789/564802 |
ISSN: | 2704137 | DOI: | 10.1002/pros.22548 | SDG/關鍵字: | antineoplastic agent; apoptosis inducing factor; ardisianone; benzoquinone derivative; mammalian target of rapamycin; protein bcl 2; protein kinase B; reactive oxygen metabolite; survivin; unclassified drug; antiproliferative activity; apoptosis; article; cell proliferation; controlled study; down regulation; endoplasmic reticulum stress; flow cytometry; human; human cell; mitochondrial membrane potential; mitochondrion; priority journal; prostate cancer; protein expression; reverse transcription polymerase chain reaction; upregulation; Western blotting; Apoptosis; Benzoquinones; Cell Line, Tumor; Down-Regulation; Humans; Inhibitor of Apoptosis Proteins; Male; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Prostatic Neoplasms; Reactive Oxygen Species |
顯示於: | 藥學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。